Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

novel, proprietary products for the acute treatment of central nervous system conditions.  Alexza's technology, the Staccato® system, vaporizes unformulated drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery through deep lung inhalation.  The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. (Click here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients.  Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted the AZ-004 NDA in December 2009.  In October 2010, the Company received a CRL from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company completed an end-of-review meeting with the FDA in late December 2010.  

The Company believes it has a clear understanding of the issues outlined in the CRL, is developing and executing a plan to address these issues, and currently projects a resubmission of the AZ-004 NDA in July 2011.  

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to two fiscal quarters, and to provide, update or reconfirm its guid
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... WELWYN GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, ... Akira Usui as a Consultant to augment the Company,s ... Asian territories. Mr Usui has more than 15 years ... pharmaceutical industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ...
(Date:5/23/2013)... OAKS, Calif. , May 23, 2013 Amgen ... Bank 38 th Annual  Healthcare Conference on Thursday, May ... Boston , beginning at 9:20 a.m. Eastern Daylight Time. ... Relations at Amgen, will present at the conference. Live audio ... on Amgen,s website, www.amgen.com , under Investors. A replay ...
(Date:5/23/2013)... recently published clinical study conducted at TOPS Comprehensive Breast ... that 3D mammography (breast tomosynthesis) significantly reduces unnecessary recalls ... study, "Implementation of Breast Tomosynthesis in a Routine Screening ... Stephen L. Rose , MD, and published in ... Roentgenology (AJR). The AJR is the scientific journal ...
Breaking Medicine Technology:Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... MINNEAPOLIS, Jan. 29 AGA Medical Corporation today launched ... Bruschi, a professional football player who suffered a stroke ... career. The unique online educational program will consist of ... Medical website that describe Tedy,s firsthand experience as a ...
... Jan. 28 Today at the American Academy of ... California at,San Diego report that no standardized practices ... Researchers looked at many factors,including: which steroids were ... a local anesthetic was mixed with the steroid. , ...
Cached Medicine Technology:AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 2AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi 3Study Shows No Standardized Approach to Epidural Steroid Injections for Back Pain 2
(Date:5/25/2013)... 2013 While some will be spending ... died serving our Country, many others will simply enjoy ... recklessness. The DUI attorneys at MacGregor & Collins, LLP ... help keep this weekend’s party-goers out of trouble. , ... were more than 950 fatal alcohol-related collisions and 16,000 ...
(Date:5/25/2013)... Dr. Leslie Gerstman announced today that Ultherapy -- ... neck, on the brow and under the chin -- is ... a non-surgical procedure for the face and neck that stimulates ... over time. The use of FDA-cleared ultrasound technology enables physicians, ... deepest support layers of the skin – typically addressed in ...
(Date:5/25/2013)... 2013 Life science and analytical reagents ... detect and create a new substance with the purpose ... also known as biotechnology reagents. Such reagents are significant ... , This market is driven by factors such as ... of therapeutics, growth in research and rapid commercialization of ...
(Date:5/25/2013)... Idaho (PRWEB) May 25, 2013 A ... prevalent type of peripheral neuropathy. According to neuropathy expert ... , it is estimated that the disorder affects almost ... common complication arising from Diabetes. The high blood sugar ... Diabetes and patients suffering from it usually tend to ...
(Date:5/25/2013)... News) -- Many viruses and parasites that affect both ... a bacteria-borne illness than can result in liver or ... according to a veterinarian. These germs could ... air, said Dr. Susan Nelson, a clinical associate professor ... these serious diseases can be fatal, even with treatment," ...
Breaking Medicine News(10 mins):Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 2Health News:Criminal Attorneys Provide Memorial Day Weekend DUI Checklist and Safety Information 3Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Hidden Dangers Dog Dog Parks 2
... with HIV reduced the risk of transmitting the virus to ... immune systems were relatively healthy, according to findings from a ... and Infectious Diseases (NIAID), part of the National Institutes of ... was slated to end in 2015 but the findings are ...
... with more than 35 years experience in breast imaging, has ... College of Radiology (ACR), the organization,s highest honor given for ... The award will be presented to Bassett May 15 at ... very proud to be recognized by my peers for my ...
... shows that the vast majority of patients at high risk ... taking statins as prescribed. That,s especially unfortunate, because the same ... and length of those patients, lives. "We found that ... are taking their prescribed dose on a regular basis after ...
... 12 (HealthDay News) -- Giving adrenalin to people with ... new research finds. There,s a high rate of ... But giving low-dose adrenaline to patients who have ... reduces the risk of severe allergic reactions. ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, May 11 ... do harbor stem cells capable of forming different parts of ... The findings, reported May 12 in the New England ... bioengineered lung tissue repair and replacement. "These cells ...
... Salamon HealthDay Reporter , WEDNESDAY, May 11 ... pancreatic cancer nearly doubled patients, survival time compared to ... trials, French researchers split a group of 342 patients ... the disease, into two groups. Half received gemcitabine, the ...
Cached Medicine News:Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 2Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 3Health News:Treating HIV-infected people with antiretrovirals significantly reduces transmission to partners 4Health News:UCLA cancer researcher wins prestigious Gold Medal from the American College of Radiology 2Health News:Study: Most at-risk patients don't adhere to statin treatment, despite real benefits 2Health News:Treat Snakebites With Adrenaline, Study Says 2Health News:Discovery of Lung Stem Cells May Herald New Treatments 2Health News:Chemo Combo May Help Stave Off Pancreatic Cancer Death 2
... Preserve your data for future generations. Most ... the solid backing plate of our gel dryer, ... a frame over them to hold the cellophane ... a frame with an open area somewhat larger ...
... data for future generations. Most gels can be ... plate of our gel dryer, covering them with ... them to hold the cellophane flat. Tut's Tombs ... an open area somewhat larger than the gel ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
... The Slimline SGD5040 Slab Gel Dryer incorporates sturdy metal ... saving design. The large surface area makes it perfect ... ones., Slim Profile 40cm x 50cm (W ... Heat Ramping Rates allows you to optimize ...
Medicine Products: